• Turnover: €1.7 million compared to €1.5 million in 2022
• Positive net income, increasing: €79k compared to -€403k in 2022
As a reminder, the Group is not publishing consolidated accounts for the 2023 financial year in order to continue to control its operating expenses.
• Outlook
o Expected rise in cosmetics sales
o Confirmation of the strong potential of nutraceutical and pharmaceutical projects
o Confidence in achieving operational balance objectives in 2024
The entire press release is online on the Plant Advanced Technologies website: www.plantadvanced.com
Plant Advanced Technologies PAT is listed on Euronext Growth™- Paris
ISIN: FR0010785790 – Mnemonic: ALPAT